Stock data

浩泰 (4131)

浩泰 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$16.54M, up 1.5% from a year earlier. EPS over the last four quarters totals -NT$0.83.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 浩泰 in Insightr